NANOBIOTIX (EPA:NANO) | Finanzwire

Basculer en Français

11006	Companies
241131	Keywords
169706	Articles
129805	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 09/02/2025 at 22:15, 1 year ago

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases

Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments
BRIEF

published on 08/27/2025 at 08:05, 1 year ago

Nanobiotix Announces Voting Rights and Shares Capital Update

Euronext Paris Voting Rights Biotechnology Shares Capital NANOBIOTIX
PRESS RELEASE

published on 08/27/2025 at 08:00, 1 year ago

Voting Rights and Shares Capital of the Company
Nanobiotix announces voting rights and shares capital details as per French Commercial Code regulations. The late-stage clinical biotech company focuses on disruptive therapies in oncology, bioavailability, and CNS disorders

Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF

published on 08/11/2025 at 11:34, 1 year 1 month ago

Threshold Crossings by The Goldman Sachs Group, Inc. at Nanobiotix

Actions Financial Market Goldman Sachs Crossing Thresholds NANOBIOTIX
BRIEF

published on 07/07/2025 at 22:20, 1 year 2 months ago

NANOBIOTIX: Reclassification and New Patent for JNJ-1900 (NBTXR3)

Patent NANOBIOTIX Regulatory JNJ-1900 Harmonization
PRESS RELEASE

published on 07/07/2025 at 22:15, 1 year 2 months ago

NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)
Nanobiotix announces regulatory harmonization and new composition of matter patent filed for JNJ-1900 (NBTXR3), aiming to reinforce global positioning of potential first-in-class radioenhancer

NANOBIOTIX JNJ-1900 Global Positioning Regulatory Harmonization Composition Of Matter Patent
BRIEF

published on 06/24/2025 at 12:39, 1 year 2 months ago

Goldman Sachs Crosses Stake Threshold in Nanobiotix

Stock Market Acquisition Of Shares Goldman Sachs Threshold Crossing NANOBIOTIX
BRIEF

published on 06/10/2025 at 22:20, 1 year 3 months ago

Number of Shares and Voting Rights of Nanobiotix

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/10/2025 at 22:15, 1 year 3 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses voting rights and shares capital. The company is a biotechnology pioneer with disruptive therapeutic approaches. Visit www.nanobiotix.com for more info

Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
BRIEF

published on 05/21/2025 at 22:20, 1 year 3 months ago

Nanobiotix Reports Q1 2025 Achievements and Financial Status

Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials

Accesswire

Published on 09/16/2026 at 23:45, 2 hours 42 minutes ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 4 hours 57 minutes ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 9 hours 32 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 11 hours 27 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 12 hours 27 minutes ago

Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/16/2026 at 23:45, 2 hours 42 minutes ago

WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 3 hours 53 minutes ago

EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 5 hours 12 minutes ago

Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 5 hours 59 minutes ago

EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 7 hours 22 minutes ago

EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026

Les Echos

Published on 09/16/2026 at 20:46, 5 hours 41 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 8 hours 42 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 8 hours 42 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 19 hours 27 minutes ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 8 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE